Article info
Letter
Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE
- Correspondence to Dr Jens Y Humrich, Department of Rheumatology and Clinical Immunology, Charité—University Medicine Berlin, Charitéplatz 1, Berlin 10117, Germany; jens.humrich{at}charite.de
Citation
Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE
Publication history
- Received August 19, 2014
- Revised December 30, 2014
- Accepted January 6, 2015
- First published January 21, 2015.
Online issue publication
March 05, 2015
Article Versions
- Previous version (21 January 2015).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions